SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

AtriCure Reports Third-Quarter 2026 Financial Results

AtriCure announced its third-quarter 2026 financial results.

ATRC

AtriCure, Inc. (NASDAQ:ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2026 financial results.“Our third quarter results demonstrate the strength…

Related stories